Genmab
GMAB
GMAB
219 hedge funds and large institutions have $1.28B invested in Genmab in 2025 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 92 increasing their positions, 66 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
219
Holders Change
-9
Holders Change %
-3.95%
% of All Funds
2.98%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.01%
New
37
Increased
92
Reduced
66
Closed
40
Calls
$15.4M
Puts
$9.44M
Net Calls
+$5.98M
Net Calls Change
+$3.42M
Top Buyers
| 1 |
OAG
Orbis Allan Gray
Hamilton,
Bermuda
|
+$56.7M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$26.2M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$26.1M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$20.7M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$16.4M |
Top Sellers
| 1 |
Capital International Investors
Los Angeles,
California
|
-$53.4M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$41.7M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$17.6M |
| 4 |
BlackRock
New York
|
-$13.3M |
| 5 |
BM
Bridger Management
New York
|
-$6.08M |
